Tag: Eisai

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Eisai

FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the ...

Added to Collection on: 2024-06-10 04:43:58

Tags for this article:

Alzheimer's disease
Amyloidosis
Lecanemab
Food and Drug Administration
Eisai
Prescription Drug User Fee Act
Amyloid beta
BioArctic AB
STOCKHOLM
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Eisai announces move to solo development and commercialization of farletuzumab ...

Added to Collection on: 2024-07-01 14:37:11

Tags for this article:

Antineoplastic drugs
Monoclonal antibodies
Orphan drugs
Eisai
Antibody-drug conjugate
Bristol-Myers Squibb
Farletuzumab
Eribulin
Amatuximab
Eisai Co . , Ltd
Japan

Click the tags to see associated articles and topics

View Article Details
Lilly drug for Alzheimer's approved by FDA | BioPharma Dive

Added to Collection on: 2024-07-02 18:38:49

Tags for this article:

Biogen
Spinal muscular atrophy
Aducanumab
Orphan drugs
Donanemab
Alzheimer's disease
Lecanemab
Accelerated approval
Eli Lilly and Company
Eisai
Alzheimer's Drug Discovery Foundation
Eli Lilly

Click the tags to see associated articles and topics

View Article Details
Lecanemab: European drug agency rejects Alzheimer's drug amid debate over efficacy and safety

Added to Collection on: 2024-07-29 14:16:42

Tags for this article:

Orphan drugs
Lecanemab
Eisai
Clinical research
Alzheimer's disease
Placebo

Click the tags to see associated articles and topics

View Article Details
England Rejects New Alzheimer's Treatment as Too Pricey - BNN Bloomberg

Added to Collection on: 2024-08-22 15:59:49

Tags for this article:

Orphan drugs
Lecanemab
Biogen
Eisai
United Kingdom

Click the tags to see associated articles and topics

View Article Details
Developing donanemab - balancing cost versus benefit - European Pharmaceutical Review

Added to Collection on: 2024-10-24 16:16:38

Tags for this article:

Alzheimer's disease
Amyloidosis
Donanemab
Lecanemab
Eisai
Biogen
Amyloid beta
Pharmaceutical industry
Eli Lilly and Company
Medication
Anti-amyloid drugs
United Kingdom

Click the tags to see associated articles and topics

View Article Details
New Phase 3 Data Suggest Benefits of Early Lecanemab Initiation on Alzheimer Disease ...

Added to Collection on: 2024-10-31 18:28:23

Tags for this article:

Alzheimer's disease
Amyloidosis
Biomarkers
Lecanemab
Dementia
Amyloid beta
Eisai
Anti-amyloid drugs
Madrid
Spain

Click the tags to see associated articles and topics

View Article Details
Lennox Gastaut Syndrome Market Expected to rise, 2034 | GlaxoSmithKline, Meda ...

Added to Collection on: 2025-01-07 21:53:21

Tags for this article:

Anticonvulsants
Orphan drugs
Neurological disorders
Syndromes
Lennox?Gastaut syndrome
Epilepsy
Soticlestat
Lamotrigine
Lundbeck
Eisai
Myoclonus
LGS
Japan
United States
United Kingdom

Click the tags to see associated articles and topics

View Article Details
Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval

Added to Collection on: 2025-02-05 18:47:36

Tags for this article:

Spinal muscular atrophy
Orphan drugs
Biogen
Lecanemab
Eisai
Amgen
Pharmaceutical industry in China

Click the tags to see associated articles and topics

View Article Details
EU's CHMP Reaffirms Positive Opinion of Alzheimer Treatment Lecanemab - NeurologyLive

Added to Collection on: 2025-03-08 16:05:14

Tags for this article:

Orphan drugs
Lecanemab
Alzheimer's disease
Amyloidosis
Aducanumab
Donanemab
Eisai
Biogen
Amyloid plaques
Anti-amyloid drugs

Click the tags to see associated articles and topics

View Article Details